Solid Biosciences Inc (SLDB)
Stock chart
Loading...
•
Purchase
•
Sale
•
Planned purchase
•
Planned sale
Net purchase
Net sale
Earnings
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-03-13 | 2025-03-11 | B Purchase | Non-Executive Director |
1,860
+169.1%
5.34USD 9,924 |
1,860 +169.1% | 5.34 | USD 9,924 | |
| 2025-02-21 | 2025-02-19 | B Purchase |
Bain Capital Life Sciences Investors, LLC Large shareholder |
1,000,000
+24.8%
4.03USD 4,030,000 |
1,000,000 +24.8% | 4.03 | USD 4,030,000 | |
| 2025-02-21 | 2025-02-19 | B Purchase | Non-Executive Director Large shareholder |
5,000,000
+73.2%
4.03USD 20,150,000 |
5,000,000 +73.2% | 4.03 | USD 20,150,000 | |
| 2025-02-19 | 2025-02-18 | B Purchase |
Adage Capital Management, L.P. Large shareholder |
252,545
+6.3%
7.56USD 1,909,240 |
252,545 +6.3% | 7.56 | USD 1,909,240 | |
| 2025-02-18 | 2025-02-14 | S Sale |
CFO & Treasurer Officer |
3,164
-8.9%
3.96USD 12,529 |
3,164 -8.9% | 3.96 | USD 12,529 | |
| 2025-02-18 | 2025-02-14 | S Sale |
Chief Operating Officer Officer |
5,561
-18.3%
3.96USD 22,022 |
5,561 -18.3% | 3.96 | USD 22,022 | |
| 2025-02-18 | 2025-02-14 | S Sale | Non-Executive Director |
1,711
-10.3%
3.96USD 6,776 |
1,711 -10.3% | 3.96 | USD 6,776 | |
| 2025-02-18 | 2025-02-14 | S Sale |
Chief Regulatory Officer Officer |
3,079
-13.8%
3.96USD 12,193 |
3,079 -13.8% | 3.96 | USD 12,193 | |
| 2025-02-18 | 2025-02-14 | S Sale |
President and CEO Executive Director |
11,365
-15.8%
3.96USD 45,005 |
11,365 -15.8% | 3.96 | USD 45,005 | |
| 2025-02-18 | 2025-02-14 | S Sale |
Chief Medical Officer Officer |
3,256
-12.5%
3.96USD 12,894 |
3,256 -12.5% | 3.96 | USD 12,894 | |
| 2025-02-18 | 2025-02-14 | S Sale |
Chief Technology Officer Officer |
2,688
-12.8%
3.96USD 10,644 |
2,688 -12.8% | 3.96 | USD 10,644 | |
| 2025-01-29 | 2025-01-28 | S Sale | Non-Executive Director |
144
-1.2%
3.11USD 448 |
144 -1.2% | 3.11 | USD 448 | |
| 2025-01-13 | 2025-01-10 | PS Planned sale |
CFO & Treasurer Officer |
4,073
-14.1%
3.89USD 15,849 |
4,073 -14.1% | 3.89 | USD 15,849 | |
| 2025-01-07 | 2025-01-06 | S Sale | Non-Executive Director |
1,056
-8.4%
4.31USD 4,551 |
1,056 -8.4% | 4.31 | USD 4,551 | |
| 2024-12-04 | 2024-12-03 | S Sale |
Chief Regulatory Officer Officer |
4,610
-24.5%
5.60USD 25,822 |
4,610 -24.5% | 5.60 | USD 25,822 | |
| 2024-12-04 | 2024-12-03 | S Sale |
President and CEO Executive Director |
11,114
-22.4%
5.60USD 62,236 |
11,114 -22.4% | 5.60 | USD 62,236 | |
| 2024-12-04 | 2024-12-03 | S Sale |
Chief Operating Officer Officer |
5,072
-24.5%
5.60USD 28,396 |
5,072 -24.5% | 5.60 | USD 28,396 | |
| 2024-12-04 | 2024-12-03 | S Sale |
Chief Technology Officer Officer |
2,777
-18.6%
5.60USD 15,551 |
2,777 -18.6% | 5.60 | USD 15,551 | |
| 2024-10-22 | 2024-10-21 | S Sale |
Chief Medical Officer Officer |
2,923
-21.0%
6.50USD 19,000 |
2,923 -21.0% | 6.50 | USD 19,000 | |
| 2024-06-11 | 2024-06-07 | B Purchase | Non-Executive Director |
1,100
+inf%
7.67USD 8,442 |
1,100 +inf% | 7.67 | USD 8,442 |